Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Cameron

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Virology|December 31, 2002
Clonotype tracking of TCR repertoires during chronic virus infectionsGeorge B Cohen, Sabina A Islam, Miriam S Noble, et al.
EMBO Molecular Medicine|March 13, 2015
Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanismsAlex Pellerin, Karel Otero, Julie M Czerkowicz, et al.
Journal of Public Health (Oxford, England)|December 6, 2011
Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding interventionB L Cullen, S J Hutchinson, S O Cameron, et al.
British Journal of Pharmacology|January 20, 2016
Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivoJ Kong, J Chuddy, I A Stock, et al.
Scientific Reports|April 25, 2018
Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-βJoseph W Arndt, Fang Qian, Benjamin A Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2022
Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse ModelScott M Wemlinger, Chelsea R Parker Harp, Bo Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
The duration of exposure to HIV modulates the breadth and the magnitude of HIV-specific memory CD4+ T cellsSouheil-Antoine Younes, Lydie Trautmann, Bader Yassine-Diab, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 11, 2003
A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healingMei Li, Hua Zhu Ke, Hong Qi, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formationKimberly O Cameron, Bruce A Lefker, Hua Z Ke, et al.
Molecular Immunology|October 12, 2005
Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitopePhilip J Norris, Jennifer D Stone, Nadezhda Anikeeva, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Virology|December 31, 2002
Clonotype tracking of TCR repertoires during chronic virus infectionsGeorge B Cohen, Sabina A Islam, Miriam S Noble, et al.
EMBO Molecular Medicine|March 13, 2015
Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanismsAlex Pellerin, Karel Otero, Julie M Czerkowicz, et al.
Journal of Public Health (Oxford, England)|December 6, 2011
Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding interventionB L Cullen, S J Hutchinson, S O Cameron, et al.
British Journal of Pharmacology|January 20, 2016
Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivoJ Kong, J Chuddy, I A Stock, et al.
Scientific Reports|April 25, 2018
Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-βJoseph W Arndt, Fang Qian, Benjamin A Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2022
Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse ModelScott M Wemlinger, Chelsea R Parker Harp, Bo Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
The duration of exposure to HIV modulates the breadth and the magnitude of HIV-specific memory CD4+ T cellsSouheil-Antoine Younes, Lydie Trautmann, Bader Yassine-Diab, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 11, 2003
A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healingMei Li, Hua Zhu Ke, Hong Qi, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formationKimberly O Cameron, Bruce A Lefker, Hua Z Ke, et al.
Molecular Immunology|October 12, 2005
Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitopePhilip J Norris, Jennifer D Stone, Nadezhda Anikeeva, et al.
Pageof 11